News and CommentsNeurocysticercosis: Changes after 25 Years of Medical Therapy
References (11)
- et al.
Neurocysticercosis: a review of current status and management
J Clin Neurosci
(2009) - et al.
Regression of cystic lesion of IV ventricle after medical treatment
Rev Clin Esp
(2009) - et al.
Therapy of parenchymal brain cysticercosis with praziquantel
N Engl J Med
(1984) - et al.
Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases
Arch Int Med
(1985) - et al.
Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts
N Engl J Med
(2001)
Cited by (18)
Parasites in the nervous system of dogs and cats
2023, Organ-Specific Parasitic Diseases of Dogs and CatsDo albendazole-loaded lipid nanocapsules enhance the bioavailability of albendazole in the brain of healthy mice?
2020, Acta TropicaCitation Excerpt :Therapeutic failures observed in parasite control in both human and veterinary medicines may be related to exposure of parasites to sub-therapeutic drug concentrations due to poor drug dissolution and/or insufficient systemic availability of the active ingredient (Ceballos et al., 2014). Medical treatment of NCC with ABZ shows a clinical improvement in treated patients, substantially improving the prognosis (García et al., 2004; Sotelo and Diaz -Olavarrieta, 2010). Nevertheless, the poor and erratic absorption of ABZ after oral administration is a disadvantage for the treatment of systemic infections such as NCC.
Neurocysticercosis
2014, Encyclopedia of the Neurological SciencesReduced percentage of neurocysticercosis cases among patients with late-onset epilepsy in the new millennium
2012, Clinical Neurology and NeurosurgeryChanging pattern of neurocysticercosis in an urban endemic center (Guayaquil, Ecuador)
2012, Journal of the Neurological SciencesCitation Excerpt :Disease burden varies according to several factors, including the socio-economic status of the population, the level of sanitation, and the degree of awareness on the mechanisms of disease acquisition [2]. It has been suggested that widespread use of cysticidal drugs together with improved sanitation and increased public awareness on the disease, could have cause a recent decrease in the number of severe cases of neurocysticercosis or even a reduction in its prevalence [3,4]. To test this hypothesis, we conducted a retrospective cohort study of patients with neurocysticercosis evaluated at our institution over a 20-year period.
Neurocysticercosis: Changes After 25 Years of Medical Therapy
2010, Archives of Medical Research